Zobrazeno 1 - 10
of 29
pro vyhledávání: '"SEMAPHORIN 4C"'
Publikováno v:
Acta Medica Bulgarica, Vol 51, Iss 4, Pp 1-7 (2024)
Introduction. The global burden of breast cancer (BC) has encouraged ceaseless research in exploring novel biomarkers, aiming to optimize BC management and prognosis.
Externí odkaz:
https://doaj.org/article/20c41c4d7c274fd9a931e0be16ea91e9
Autor:
Ya Wang, Long Qiao, Jie Yang, Xiong Li, Yaqi Duan, Jiahao Liu, Shaoqi Chen, Huayi Li, Dan Liu, Tian Fang, Jingjing Ma, Xiaoting Li, Fei Ye, Junxiang Wan, Juncheng Wei, Qin Xu, Ensong Guo, Ping Jin, Mingfu Wu, Lin Zhang, Yun Xia, Yaqun Wu, Jun Shao, Yaojun Feng, Qing Zhang, Zongyuan Yang, Gang Chen, Qinghua Zhang, Xingrui Li, Shixuan Wang, Junbo Hu, Xiaoyun Wang, Mona P. Tan, Kazuaki Takabe, Beihua Kong, Qifeng Yang, Ding Ma, Qinglei Gao
Publikováno v:
Cancer Communications, Vol 41, Iss 12, Pp 1373-1386 (2021)
Abstract Background To date, there is no approved blood‐based biomarker for breast cancer detection. Herein, we aimed to assess semaphorin 4C (SEMA4C), a pivotal protein involved in breast cancer progression, as a serum diagnostic biomarker. Method
Externí odkaz:
https://doaj.org/article/4e35427d50514982972a9b3fc4530215
Publikováno v:
Visualized Cancer Medicine, Vol 4, p 6 (2023)
Semaphorins constitute a diverse family of widely expressed transmembrane, diffusible, and GPI-linked proteins with versatile physiologic functions in orchestrating nerve system development, immune homeostasis, angiogenesis, and cell metabolism. Accu
Externí odkaz:
https://doaj.org/article/7334c7b653c64d288fc5a6bbbdf6e2b9
Autor:
Beihua Kong, Ping Jin, Jingjing Ma, Xingrui Li, Long Qiao, Qing Zhang, Qinglei Gao, Qinghua Zhang, Zongyuan Yang, Qin Xu, Xiaoting Li, Qifeng Yang, Lin Zhang, Xiong Li, Dan Liu, Ya Wang, Tian Fang, Jun Shao, Junbo Hu, Mingfu Wu, Mona P. Tan, Shixuan Wang, Ding Ma, Yaojun Feng, Yaqun Wu, Fei Ye, Kazuaki Takabe, Yaqi Duan, Ensong Guo, Gang Chen, Shaoqi Chen, Yun Xia, Huayi Li, Xiaoyun Wang, Jie Yang, Jiahao Liu, Junxiang Wan, Juncheng Wei
Publikováno v:
Cancer Communications
Cancer Communications, Vol 41, Iss 12, Pp 1373-1386 (2021)
Cancer Communications, Vol 41, Iss 12, Pp 1373-1386 (2021)
Background To date, there is no approved blood‐based biomarker for breast cancer detection. Herein, we aimed to assess semaphorin 4C (SEMA4C), a pivotal protein involved in breast cancer progression, as a serum diagnostic biomarker. Methods We incl
Publikováno v:
Bioengineered
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10117-10125 (2021)
article-version (VoR) Version of Record
Bioengineered, Vol 12, Iss 2, Pp 10117-10125 (2021)
In view of the role of miR-138 in cancer cells, we predicted the target of miR-138 and its targeting to SEMA4C by bioinformatics software and luciferase experiment. The expression levels of miR-138 in human normal breast epithelial cells and two kind
Publikováno v:
Experimental and Therapeutic Medicine
Although lymphatic endothelial cells (LECs) serve a positive role in tumor lymphatic metastasis, the regulation of LECs undergoing migration similar to that of tumor cells remains poorly understood. A previous study revealed that semaphorin 4C (Sema4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ivana Sarotto, Giulia Franzolin, Anna Sapino, Enzo Medico, Massimo Accardo, Claudio Isella, Damon Fard, Luca Tamagnone, Sreeharsha Gurrapu
Publikováno v:
Science signaling. 12(595)
Semaphorins are a family of molecular signals that guide cell migration and are implicated in the regulation of cancer cells. In particular, transmembrane semaphorins are postulated to act as both ligands ("forward" mode) and signaling receptors ("re
Autor:
Gabriel N. Kaufman, Walid Mourad, Marianne Beland, Eisha Ahmed, Marylin Desjardins, Salem Al-Tamemi, Di Xue, Shao Tao, Roland H. Friedel, Bruce Mazer
Publikováno v:
Frontiers in Immunology. 8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.